Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 3vrz.2 (1 other biounit)

Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.22 Å
Oligo State
monomer
Ligands
1 x CA: CALCIUM ION(Non-covalent)
1 x CL: CHLORIDE ION(Non-functional Binders)
1 x VRZ: 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Saito, Y. et al., A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo. Sci Transl Med (2013)
Release Date
2013-05-01
Peptides
Tyrosine-protein kinase HCK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
B

Tyrosine-protein kinase HCK

Related Entries With Identical Sequence

1qcf.1 | 2c0i.1 | 2c0i.2 | 2c0o.1 | 2c0o.2 | 2c0t.1 | 2c0t.2 | 3vry.1 | 3vry.2 | 3vrz.1 | 3vs0.1 | 3vs0.2 | 3vs1.1 | 3vs1.2 | 3vs2.1 | 3vs2.2 | 3vs3.1 | 3vs3.2 | 3vs4.1 | 3vs4.2 | 3vs5.1 | 3vs5.2 | 3vs6.1 | 3vs6.2 | 3vs7.1 | 3vs7.2 | 4lud.1 | 4lud.2 | 4lue.1 | 4lue.2  more...